MR

Mohammad Rafeek

Active Director Director DIN 05325890
DIN 05325890 First appointment Aug 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2012
Shareholding value •••• Premium profile

About Mohammad Rafeek

Data last updated:

Mohammad Rafeek is a Director at Galaxyline Biocare Private Limited (since 2012). The company operates in Chemicals. Galaxyline Biocare Private Limited reported revenue of ₹1.2 Lakh (FY 2019).

DIN 05325890
Primary Designation Director
Industry Chemicals
First Appointment 06 Aug 2012
Oldest Company Age 14 yrs
Largest company Galaxyline Biocare Private Limited · ₹1.2 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Galaxyline Biocare Private Limited U74120UP2012PTC051809
Director06 Aug 20122012₹1.2 Lakh (FY 2019)Active

Board colleagues of Mohammad Rafeek

Directorship timeline

Open interactive timeline →
Galaxyline Biocare Private Limited
Premium access

Shareholding and investment profile for Mohammad Rafeek

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammad Rafeek

Mohammad Rafeek currently holds 1 directorship: Galaxyline Biocare Private Limited (Director, since 06 Aug 2012, revenue ₹1.2 Lakh (FY 2019)).

Mohammad Rafeek was first appointed on 06 Aug 2012 as Director at Galaxyline Biocare Private Limited.

The current boards of Mohammad Rafeek's companies include Hifzurrehman (Galaxyline Biocare Private Limited), Tripuresh (Galaxyline Biocare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available